209 filings
Page 9 of 11
8-K
2f3iodqb2miv 1aq8h
18 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
5pi9zy0tszt
5 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
io95s18rdt14mxtpmds
12 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K
r10o6
29 May 13
Regulation FD Disclosure
12:00am
8-K
9n6c9 jmx6c2alahhu
7 May 13
Entry into a Material Definitive Agreement
12:00am
8-K
q6owyrvrbx9hzk4 m9eu
29 Mar 13
Entry into a Material Definitive Agreement
12:00am
8-K
xlp3ygv5skk1qo93ha
8 Mar 13
Entry into a Material Definitive Agreement
12:00am
8-K
xfdh80m
5 Dec 12
Regulation FD Disclosure
12:00am
8-K
ajta6pt xy1
3 Dec 12
Regulation FD Disclosure
12:00am
8-K
cfvj19ye
20 Sep 12
Regulation FD Disclosure
12:00am
8-K
o5vru8l65jop
30 Aug 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
fwbi53pumcxeva
30 Aug 12
Regulation FD Disclosure
12:00am
8-K
8ogel20uveytqxkd
16 Jul 12
ChromaDex® Licenses Exclusive Patent Rights for Nicotinamide Riboside (NR) Vitamin Technologies from Dartmouth College
12:00am
8-K
y2g jlw8g901v
12 Jun 12
ChromaDex® Corp. Names Co-founder Frank Jaksch CEO & President
12:00am
8-K
czc9f cjj2fowrqj9qst
24 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
h6uj8idlab9c7av5k
17 Feb 12
ChromaDex Announces Management Changes
12:00am
8-K
p6qv2
14 Feb 12
Unregistered Sales of Equity Securities
12:00am
8-K
o0zqzki87a a7m8blsz
13 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
zon9y2f8
1 Feb 12
ChromaDex® to Raise $10.85M in Sale of Common Stock
12:00am
8-K
x13 4l1d11oyyy
27 Jan 12
Regulation FD Disclosure
12:00am